L
ADING

Research & Development

Ulcerative Colitis
Lipid Therapeutics today announced that it has entered into a licensing agreement with Nestl' Health Science
Apaziquone set for Phase Three Trial
Spectrum Pharmaceuticals announces agreement with FDA on the Special Protocol Assessment (SPA)
Accelerated Assessment for Ixazomib
European Medicines Agency Grants Accelerated Assessment of Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma
Evidence Shows New Technique Spares More Breast Cancer Suffers� Nipples
A new study published in the journal Plastic and Reconstructive Surgery proves that more breast cancer patients can qualify for
Researchers Reap Rewards
Two top researchers into Alzheimer's disease receive the 2015 MetLife Foundation Awards for Medical Research
CHMP Recommends Levemir� for Treatment of Diabetes of 1 Year Olds
The Committee for Medicinal Products for Human Use has recommended Levemir' is offered to children as young as one year
Report on Importance of Continued Research into Cancer Therapy Drugs after Approval
A new report by Boston Healthcare has analysed the limitations of FDA approval with regards to cancer drugs
Stem Cells  Could Expand Window  for Treating Stroke
A recent study in STEM CELLS Translational Medicine could open the door to a new therapy
How Do You Solve a Problem Like Non-Adherence?
Several factors have a direct influence on adherence.
Will Theranos Turn the Lab Industry Upside Down?
Theranos has received much praise along with a healthy dose of skepticism in recent months
Actavis Announces Trial Results
Company reveals outcome of Topline Phase 3 Clinical Trial for Single-Dose DALVANCE' (dalbavancin) in the Treatment of ABSSSI
First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients
Merrimack Pharmaceuticals, Inc. has announced updated clinical data from a multi-arm Phase 1 study of MM-141, a bispecific antibody targeting